The potentials of short fragments of human anti-microbial peptide LL-37 as a novel therapeutic modality for diseases

The potentials of short fragments of human anti-microbial peptide LL-37 as a novel therapeutic modality for diseases

Human cathelicidin antimicrobial peptide LL-37 (LL-37) is an antimicrobial peptide derived from its precursor protein hCAP18, which is an only cathelicidin in human. LL-37 not only serves as a mediator of innate immune defense against invading microorganisms, but it also plays an essential role in t...

Full description

Bibliographic Details
Main Authors:	Keqiang Chen, Wanghua Gong, Jiaqiang Huang, Teizo Yoshimura, Ji Ming Wang
Format:	Article
Language:	English
Published:	IMR Press 2021-11-01
Series:	Frontiers in Bioscience-Landmark
Subjects:	ll-37 short peptides immunoregulation infection cancer
Online Access:	https://www.imrpress.com/journal/FBL/26/11/10.52586/5029

Similar Items

The Potential of Human Peptide LL-37 as an Antimicrobial and Anti-Biofilm Agent
by: Kylen E. Ridyard, et al.
Published: (2021-05-01)

Renovation as innovation: Repurposing human antibacterial peptide LL-37 for cancer therapy
by: Fatai Lu, et al.
Published: (2022-08-01)

Evaluating the Antiviral Activities of Human Cathelicidin LL-37 Peptide Against Rotavirus in Vitro
by: Zohreh Hosseini, et al.
Published: (2019-08-01)

The human cathelicidin antimicrobial peptide LL-37 and mimics are potential anticancer drugs
by: Kengo eKuroda, et al.
Published: (2015-06-01)

Salivary concentration of the antimicrobial peptide LL-37 in patients with oral lichen planus
by: Sotiria Davidopoulou, et al.
Published: (2014-12-01)

Cord blood antimicrobial peptide LL37 levels in preterm neonates and association with preterm complications
by: Zhuxiao Ren, et al.
Published: (2022-07-01)

Regulation of LL-37 in Bone and Periodontium Regeneration
by: Zahra Chinipardaz, et al.
Published: (2022-09-01)

Structural Plasticity of LL-37 Indicates Elaborate Functional Adaptation Mechanisms to Bacterial Target Structures
by: Kornelius Zeth, et al.
Published: (2021-05-01)

Citrullination Alters the Antiviral and Immunomodulatory Activities of the Human Cathelicidin LL-37 During Rhinovirus Infection
by: Víctor Casanova, et al.
Published: (2020-02-01)

A Simple Synthesis and Microstructure Analysis of Human Peptide LL-37@Gold Nanoparticles (Known as LL-37@AuNPs) Conjugates as Antimicrobials and Substances for Wound Healing
by: Subaer Subaer, et al.
Published: (2023-12-01)

Backbone Cyclization and Dimerization of LL-37-Derived Peptides Enhance Antimicrobial Activity and Proteolytic Stability
by: Sunithi Gunasekera, et al.
Published: (2020-02-01)

Serum LL‐37 and inflammatory cytokines levels in psoriasis
by: Juanfeng Lao, et al.
Published: (2023-03-01)

Long-Lasting Stable Expression of Human LL-37 Antimicrobial Peptide in Transgenic Barley Plants
by: Malihe Mirzaee, et al.
Published: (2021-07-01)

Immunomodulatory Role of the Antimicrobial LL-37 Peptide in Autoimmune Diseases and Viral Infections
by: Bapi Pahar, et al.
Published: (2020-09-01)

Cloning, Expression, and Purification of Antimicrobial Peptide LL-37 and Assessment of its Antimicrobial Effectiveness on Multiple-Drug-Resistant Acinetobacter Baumannii
by: Ehsan Zarei-Mehrvarz, et al.
Published: (2017-10-01)

LL-37: Structures, Antimicrobial Activity, and Influence on Amyloid-Related Diseases
by: Surajit Bhattacharjya, et al.
Published: (2024-03-01)

LEVELS OF LL-37 ANTIMICROBIAL PEPTIDE IN THE GINGIVAL CREVICULAR FLUID OF YOUNG AND MIDDLE-AGED SUBJECTS WITH OR WITHOUT GINGIVITIS
by: Oya TÜRKOĞLU, et al.
Published: (2017-01-01)

In Vitro Antifungal Activity of LL-37 Analogue Peptides against <i>Candida</i> spp.
by: Gladys Pinilla, et al.
Published: (2022-11-01)

Expression and significance of serum vitamin D and LL-37 levels in infants with bacterial pneumonia
by: Shaojie Zhao, et al.
Published: (2022-11-01)

Design and heterologous expression of a novel dimeric LL37 variant in Pichia pastoris
by: Na Zhan, et al.
Published: (2021-07-01)

Antimicrobial Peptide LL-37 and IDR-1 Ameliorate MRSA Pneumonia in Vivo
by: Man Hou, et al.
Published: (2013-09-01)

Evaluation of plasma antimicrobial peptide LL-37 and nuclear factor-kappaB levels in stable chronic obstructive pulmonary disease
by: Uysal P, et al.
Published: (2019-01-01)

CXCR2 specific endocytosis of immunomodulatory peptide LL-37 in human monocytes and formation of LL-37 positive large vesicles in differentiated monoosteophils
by: Zhifang Zhang, et al.
Published: (2020-06-01)

Circulating Antimicrobial Peptide LL-37 Status in Type 1 Diabetes Mellitus and its Relation with Glycemic Control
by: Himika Chawla, et al.
Published: (2017-04-01)

Spotlight on Human LL-37, an Immunomodulatory Peptide with Promising Cell-Penetrating Properties
by: Marc Ferdinand Lensink, et al.
Published: (2010-11-01)

The Human Antimicrobial Peptides Dermcidin and LL-37 Show Novel Distinct Pathways in Membrane Interactions
by: Kornelius Zeth, et al.
Published: (2017-11-01)

The serum level of the immunomodulatory peptide cathelicidin LL37 and T helper cell type 1 inflammatory response in viral hepatitis B, C, and D
by: Iacob Simona Alexandra, et al.
Published: (2013-03-01)

The impact of cathelicidin, the human antimicrobial peptide LL-37 in urinary tract infections
by: Ibrahim H. Babikir, et al.
Published: (2018-01-01)

Super-Resolution Microscopy Reveals a Direct Interaction of Intracellular <i>Mycobacterium tuberculosis</i> with the Antimicrobial Peptide LL-37
by: Dhruva Deshpande, et al.
Published: (2020-09-01)

Complexation of fungal extracellular nucleic acids by host LL-37 peptide shapes neutrophil response to Candida albicans biofilm
by: Magdalena Juszczak, et al.
Published: (2024-02-01)

Efficacy of Cathelicidin LL-37 in an MRSA Wound Infection Mouse Model
by: Oriana Simonetti, et al.
Published: (2021-10-01)

LL-37 Triggers Antimicrobial Activity in Human Platelets
by: Francisco Javier Sánchez-Peña, et al.
Published: (2023-02-01)

NMR structure and bactericidal activity of KR-12 analog derived from human LL-37 as a potential cosmetic preservative
by: Hyosuk Yun, et al.
Published: (2020-05-01)

LL-37 Might Promote Local Invasion of Melanoma by Activating Melanoma Cells and Tumor-Associated Macrophages
by: Kentaro Ohuchi, et al.
Published: (2023-03-01)

Sphingosine-1-Phosphate-Triggered Expression of Cathelicidin LL-37 Promotes the Growth of Human Bladder Cancer Cells
by: Tomasz Wollny, et al.
Published: (2022-07-01)

Structure and Activity of a Selective Antibiofilm Peptide SK-24 Derived from the NMR Structure of Human Cathelicidin LL-37
by: Yingxia Zhang, et al.
Published: (2021-11-01)

Citrullination-Resistant LL-37 Is a Potent Antimicrobial Agent in the Inflammatory Environment High in Arginine Deiminase Activity
by: Danuta Bryzek, et al.
Published: (2020-11-01)

Quorum Sensing Pseudomonas Quinolone Signal Forms Chiral Supramolecular Assemblies With the Host Defense Peptide LL-37
by: Ferenc Zsila, et al.
Published: (2021-10-01)

An M protein coiled coil unfurls and exposes its hydrophobic core to capture LL-37
by: Piotr Kolesinski, et al.
Published: (2022-06-01)

Anti-Carbamylated LL37 Antibodies Promote Pathogenic Bone Resorption in Rheumatoid Arthritis
by: Liam J. O’Neil, et al.
Published: (2021-09-01)